This is a preview of subscription content, log in via an institution to check access.
Reference
Donges E, et al. Patterns in use and costs of conventional and biologic disease-modifying anti-rheumatic drugs in Australia. Clinical and Experimental Rheumatology : 18 Apr 2017. Available from: URL: http://doi.org/11518 [pii]
Rights and permissions
About this article
Cite this article
Biologic DMARDs "a burgeoning cost" in Australia. PharmacoEcon Outcomes News 777, 7 (2017). https://doi.org/10.1007/s40274-017-3946-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-3946-3